(Reuters) – European shares rebounded on Monday after a Wall Street-led rout in technology stocks kept global sentiment subdued in the previous week, with investors keeping a close watch on COVID-19 vaccine developments.
Australia expects to receive its first batches of a potential COVID-19 vaccine in January after a deal was struck with CSL (AX:) to manufacture two vaccines – one developed by rival AstraZeneca (L:) and Oxford University, and another in CSL’s own labs with the University of Queensland.
AstraZeneca rose 1.5%. The European healthcare sector index () jumped 0.9%.
The STOXX 600 index () was 0.8% higher by 0709 GMT, with Frankfurt shares () leading gains after rising 1%.
Shares of insurers (), banks () and automakers () climbed more than 1% in early trading.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.